Sustained Response to Reduced‐Dose Trametinib in Refractory Darier Disease: A Case Report
The authors declare no conflicts of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request.
Authors
- Diego Soto‐García (ORCID: https://orcid.org/0000-0001-6559-3108)
- Michael Ziv (ORCID: https://orcid.org/0000-0003-4762-899X)
- Or Haskel
- Elena Didkovsky (ORCID: https://orcid.org/0000-0001-7375-264X)
- Roni P. Dodiuk‐Gad (ORCID: https://orcid.org/0000-0003-2168-3798)
- Gil Bar‐Sela
Institutions
- Tel Aviv University (IL)
- Technion – Israel Institute of Technology (IL)
- University of Toronto (CA)
- Emek Medical Center (IL)
- Rabin Medical Center (IL)
- University Hospital Complex Of Vigo (ES)
Publication Details
- Journal
- International Journal of Dermatology
- Published
- 2026-09-11
- DOI
- https://doi.org/10.1111/ijd.70683
- Primary Topic
- Genetic and rare skin diseases.
- Type
- article
- Field-Weighted Citation Impact
- 0.00